Viewing Study NCT05767866


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2025-12-27 @ 10:41 AM
Study NCT ID: NCT05767866
Status: UNKNOWN
Last Update Posted: 2023-03-17
First Post: 2023-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR
Sponsor: Suzhou Puhe Pharmaceutical Technology Co., LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module